Institutions | About Us | Help | Gaeilge
rian logo


Mark
Go Back
4th annual conference on Clinical Trials in Alzheimer's Disease: Highlights
Alzheimer Research Forum
��In a sign that researchers are grappling with therapy development, the 4th annual conference on Clinical Trials in Alzheimer's Disease was filled beyond its venue's capacity, drawing 522 researchers from around the globe. Held 3-5 November 2011 in San Diego, CTAD is the brainchild of Paul Aisen, Jacques Touchon, Bruno Vellas, and Michael Weiner. The conference posted no ringing trial successes. Instead, scientists worked on methodological aspects they hope will improve future trials' chances. They discussed Bayesian models, simulated placebos, and biomarker data standards. They presented alternative outcome measures to the ADAS-cog, ranging widely from composite scales that are sensitive early on to continuous measures that encompass a patients' day-to-day variability. They focused on EEG, and on a collective effort to develop patient-reported outcomes. Highlights include:Whence and Where To: History and Future of AD Therapy Trials��Webinar: Evolution of AD Trials��Nutrient Formulation Appears to Grease Memory Function��Door Slams on RAGE��Clinical Trials: Making "Protocols From Hell" Less Burdensome��EEG: Coming in From the Margins of Alzheimer's Research?��EEG: Old Method to Lend New Help in AD Drug Development?������
Keyword(s): Dementia; Memory
Publication Date:
2011
Type: Report
Peer-Reviewed: Unknown
Language(s): English
Institution: All Ireland Public Health Repository
Publisher(s): CARDI
First Indexed: 2015-12-19 06:10:04 Last Updated: 2017-01-17 07:00:06